Dana-Farber Cancer Institute/Boston Children's Hospital
Dana-Farber Cancer Institute/Boston Children's Hospital
Boston, Massachusetts, United States2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Early Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell Transplantation | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Active, not recruiting | Phase 2 | 2026-09-24 | NCT04018937 | |
| TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients | Bronchiolitis Obliterans, Cytopenia, Hemic and Lymphatic Diseases, Pneumonia, Interstitial, blood platelet disease, bronchial disorder, bronchiolitis, bronchitis, diffuse alveolar hemorrhage, hematologic disorder, interstitial lung disease, lung disorder, obstructive lung disease, respiratory system disorder, thrombocytopenia, thrombotic microangiopathy | Recruiting | Not stated | 2026-06-22 | NCT04098445 |